“Biologicals are growing rapidly, but the market remains fragmented and difficult to navigate – especially for retailers trying to determine what works, how to deploy it, and how to deliver consistent results,” said Mike Steffeck, CEO of HGS BioScience.
“By bringing together HGS, NutriAg, and now Pharmgrade, we are building something different: a single, integrated platform with the scale, science, and manufacturing depth to consistently deliver solutions that work in the field. Pharmgrade adds critical capabilities in microbials – one of the largest and fastest-growing segments of the market – and strengthens our ability to stack technologies and deliver multiple modes of action that drive real, measurable ROI for growers,” said Mike.
The company operates a vertically integrated manufacturing network across North America. This allows HGS BioScience to maintain strong quality standards, reliable supply, and cost-effective production. It also ensures timely delivery of products to retailers and growers.
Through strong partnerships with distributors and retailers in the United States, Canada, and international markets, HGS BioScience continues to expand its reach. The platform is designed to support modern farming needs, improve crop performance, and provide measurable returns for growers.
With this acquisition, HGS BioScience becomes one of the most comprehensive biological crop solution platforms in North America. The company aims to be a trusted long-term partner for retailers and growers seeking effective and sustainable farming tools.
Photo Credit: gettyimages-anna-tarazevich